|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.86 CHF | -8.92% |
|
-.--% | - |
| 08-10 | Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says | MT |
| 08-10 | Innate Pharma surges after a deal that secures its cash runway for another year |  |
| Market Cap | 90.49B 105B 84.58B 77.3B 146B 9,969B 148B 992B 389B 4,987B 392B 384B 16,611B | P/E 2026 * |
12x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 118B 95.25B 87.05B 164B 11,227B 167B 1,117B 438B 5,617B 442B 432B 18,706B | EV / Sales 2026 * |
2.15x | EV / Sales 2027 * | 1.95x |
| Free-Float |
88.34% | Yield 2026 * |
5.63% | Yield 2027 * | 5.96% |
Last Transcript: Sanofi
| 1 day | -8.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.92% | -.--% | - | - | 105B | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| +0.08% | +4.36% | +51.56% | +40.79% | 368B | |
| +0.19% | +2.28% | +32.72% | +40.38% | 298B | |
| +0.17% | +2.35% | +8.88% | +8.94% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +1.00% | +0.46% | -4.22% | -50.21% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | -0.60% | +1,657.21% | +35.36% | +46.39% | 409.37B | |
| Weighted average by Cap. | -0.14% | +1,331.50% | +52.04% | +68.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.51B 54.88B 44.4B 40.58B 76.48B 5,234B 77.67B 521B 204B 2,618B 206B 202B 8,720B | 50.61B 58.46B 47.3B 43.23B 81.47B 5,576B 82.75B 555B 218B 2,789B 220B 215B 9,290B |
| Net income | 7.94B 9.17B 7.42B 6.78B 12.78B 875B 12.98B 87.04B 34.15B 438B 34.44B 33.69B 1,458B | 9.27B 10.7B 8.66B 7.92B 14.92B 1,021B 15.15B 102B 39.86B 511B 40.19B 39.32B 1,701B |
| Net Debt | 11.42B 13.19B 10.67B 9.75B 18.38B 1,258B 18.66B 125B 49.1B 629B 49.51B 48.43B 2,095B | 8.23B 9.51B 7.69B 7.03B 13.25B 907B 13.46B 90.23B 35.41B 454B 35.71B 34.93B 1,511B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
